title: [Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (ÖGHO)].
abstract: Immune Thrombocytopenia (ITP) is a rare and - in most patients - mild disease, but might be associated with severe or even life-threatening bleeding complications. The treatment of ITP has partly changed in recent years, due to new therapeutic options. International guidelines changed accordingly. This consensus statement by the Austrian Society of Hematology and Oncology (OEGHO) is not a new evaluation of the current evidence, but rather tries to discuss the available international guidelines and adapt them to the situation in Austria. The subject is primary ITP in adults only. Classification, epidemiology, clinical presentation and diagnostics of ITP, and especially the management of this disease, are discussed in detail. This includes current aspects of first, second, and third line therapies, splenectomy with its indications and contraindications, and the use of new therapeutic options like thrombopoetin receptor agonists (TRA).
authors.affiliation: Univ.-Klin. f. Innere Med. I, Med. Univ. Wien, Wien, Austria. ingrid.pabinger@meduniwien.ac.at
authors.forename: Ingrid
authors.initials: I
authors.lastname: Pabinger
authors.forename: Günther
authors.initials: G
authors.lastname: Gastl
authors.forename: Michael
authors.initials: M
authors.lastname: Steurer
authors.forename: Siegfried
authors.initials: S
authors.lastname: Sormann
authors.forename: Michael
authors.initials: M
authors.lastname: Fillitz
authors.forename: Josef
authors.initials: J
authors.lastname: Friedl
authors.forename: Dietmar
authors.initials: D
authors.lastname: Geissler
authors.forename: Klaus
authors.initials: K
authors.lastname: Geissler
authors.forename: Richard
authors.initials: R
authors.lastname: Greil
authors.forename: Paul
authors.initials: P
authors.lastname: Knöbl
authors.forename: Sibylle
authors.initials: S
authors.lastname: Kozek-Langenecker
authors.forename: Peter
authors.initials: P
authors.lastname: Krippl
authors.forename: Paul
authors.initials: P
authors.lastname: Kyrle
authors.forename: Alois
authors.initials: A
authors.lastname: Lang
authors.forename: Werner
authors.initials: W
authors.lastname: Linkesch
authors.forename: Heinz
authors.initials: H
authors.lastname: Ludwig
authors.forename: Markus
authors.initials: M
authors.lastname: Müller
authors.forename: Simon
authors.initials: S
authors.lastname: Panzer
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Pittermann
authors.forename: Josef
authors.initials: J
authors.lastname: Thaler
authors.forename: Ansgar
authors.initials: A
authors.lastname: Weltermann
mesh_terms: D000328:Adult; D001317:Austria; D003245:Consensus Statements as Topic; D006405:Hematology / Q000592:standards*; D006801:Humans; D008495:Medical Oncology / Q000592:standards*; D017410:Practice Guidelines as Topic; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000175:diagnosis* / Q000628:therapy*